Shares of Peloton Interactive Inc. tumbled in pre-market trading following a drop in revenue and ongoing difficulties in maintaining its subscriber base during the last quarter. It appears Chief Executive Barry McCarthy’s turnaround plan is faltering as America’s anti-obesity craze, courtesy of GLP-1-based weight loss drugs such as Wegovy and Mounjaro made by Novo Nordisk and Eli Lilly, is an easier weight loss solution than hoping on an overpriced bike with a giant iPad while being yelled at by an instructor for a 20 minute HIIT workout.